Treatment with the immunotherapy dostarlimab showed promising results in a small trial of a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN’s Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center.
More News
Pro-Palestinian movement is ‘mushrooming’ on campuses across US | CNN
Fmr. defense secy reacts to Supreme Court Trump immunity case | CNN
Should Clarence Thomas recuse on Jan.6 cases? | CNN Politics